Russia has announced the development of an mRNA vaccine targeting cancer, which will be distributed free of charge to cancer patients, according to the Russian news agency TASS. This groundbreaking development was confirmed by Andrey Kaprin, General Director of the Radiology Medical Research Center under the Russian Ministry of Health, during an interview with Radio Rossiya.
Collaborative Effort in Cancer Vaccine Development
The vaccine, created in partnership with several research centers, is slated for public release by early 2025. Pre-clinical trials have shown promising results, demonstrating the vaccine’s ability to suppress tumor growth and reduce the risk of metastases, as reported by Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology.
Understanding mRNA Vaccines
mRNA (messenger RNA) vaccines work by instructing cells to produce a protein or protein fragment similar to one found in a pathogen. This triggers an immune response, teaching the body to recognize and combat the disease. In the case of cancer, the mRNA vaccine delivers tailored instructions to target cancer cells effectively.
AI Speeds Up Personalized Vaccine Creation
In a prior interview with TASS, Mr. Gintsburg revealed that artificial neural networks could dramatically accelerate the creation of personalized cancer vaccines. While current methods require significant computation time, integrating AI techniques could reduce the process to just 30 to 60 minutes.
“We are collaborating with the Ivannikov Institute to use AI-driven neural networks for faster mathematical computations. This advancement will enable the rapid development of customized mRNA vaccines for individual patients,” Gintsburg explained.
With this innovation, Russia aims to revolutionize cancer treatment and make advanced healthcare accessible to all.
source: ndtv.com